rt-PA: Clinical Trials

2 trials of rt-PA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow rt-PA: new trials by email Literature Review of rt-PA trials Research Report on rt-PA

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
Eptifibatide, rt-PA - Ischemic Stroke, Stroke
Phase 2CompletedUniversity of Cincinnati1262009-07-012014-04-17
Clinical Trial on Treatment of Intraventricular Hemorrhage
tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo) - Intraventricular Hemorrhage
Phase 2CompletedJohns Hopkins University522004-02-012017-12-11

Conditions studied

Brain Infarction (1)  ·  Ischemic Stroke (1)  ·  Stroke (1)  ·  Thrombosis (1)

Sponsors

Johns Hopkins University (1)  ·  University of Cincinnati (1)

Countries

United States (2)  ·  Canada (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Arthur M Pancioli, MD (1)  ·  Daniel F Hanley, MD (1)  ·  Opeolu M Adeoye, MD (1)

Results publications

PMID 21940973, PMID 22382155, PMID 22474059, PMID 23370203, PMID 23463422, PMID 23887841, PMID 26228884